Netherlands, Oct. 27 -- NEC Corporation announced its participation in PREPAIR VAC, a Horizon Europe-funded research project aimed at strengthening pandemic preparedness through the application of artificial intelligence (AI) in vaccine design. The grant has been awarded to NEC OncoImmunity AS (NOI)-a wholly owned subsidiary of NEC Bio within NEC Corporation-alongside several European partners comprising a research consortium.This four-year research grant beginning in September 2026, with a total budget of approximately €6.5M, aims to address major challenges in vaccine design in the context of pandemic preparedness, bringing together leading organizations across the vaccine development ecosystem. European partners from academia, indu...